-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE PHARMACEUTICALS ANNOUNCES FIRST EUROPEAN STUDY PARTICIPANT ENROLLED IN REVERA-301 PHASE 3 CLINICAL TRIAL

Reuters·10/09/2026 12:00:00

Please log in to view news